The University of Chicago Header Logo

Connection

Ezra Cohen to Immunoenzyme Techniques

Back to Details
This is a "connection" page, showing publications Ezra Cohen has written about Immunoenzyme Techniques.
Ezra Cohen
Connection Strength
0.035
Immunoenzyme Techniques
  1. Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial. Lancet Oncol. 2016 Sep; 17(9):1272-82.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.